Basel Medical Group Ltd Ordinary Shares

BMGL | NASDAQ

$5.09

+$0.05 (+0.99%)

Nov 2, 2026, 3:13 PM ET · Market open

Fiscal Year Period Ending	FY 2024 Jun 30, 2025	FY 2023 Jun 30, 2024	FY 2022 Jun 30, 2023	FY 2021 Jun 30, 2022
Cash & Equivalents	2.98M	1.95M	1.22M	1.56M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	49	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	2.49M	12.44M	13.33M	13.88M
Inventory	376.29K	72.03K	94.6K	69.83K
Other Current Assets	31.8K	1.59M	n/a	n/a
Total Current Assets	13.12M	16.17M	14.77M	15.67M
Property-Plant & Equipment	3.45M	57.97K	578.78K	1.18M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.74M	134.98K	606.35K	1.18M
Total Assets	16.85M	16.31M	15.38M	16.85M
Account Payables	2.1M	829.32K	1.46M	1.08M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	61.37K	2.68M	3.22M	3.63M
Other Current Liabilities	15K	458.32K	490.73K	405.5K
Total Current Liabilities	10.69M	7.16M	6.47M	7.19M
Long-Term Debt	n/a	1.58M	3.4M	5.31M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.3M	1.58M	3.42M	5.95M
Total Liabilities	11.99M	8.75M	9.89M	13.14M
Total Debt	3.42M	4.29M	7.21M	10.15M
Book Value	4.86M	7.56M	5.49M	3.71M
Book Value Per Share	3.11	5.58	4.05	2.74
Common Stock	34.21M	24.46M	8	8
Retained Earnings	-4.4M	7.56M	5.49M	3.71M
Comprehensive Income	-24.95M	-24.46M	n/a	n/a
Shareholders Equity	4.86M	7.56M	5.49M	3.71M
Total Investments	49	n/a	n/a	n/a